What You Should Know – A new McKinsey & Company report reveals that Health Services Technology (HST) has become the fastest-growing segment in U.S. healthcare,

Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in US supermarkets as a growing number of Americans try obesity

A growing list of restaurants are packing their menus with protein as more Americans opt for healthier diets.  Subway recently announced that it was kicking

Oprah Winfrey has massively influenced wellness and diet culture for decades, now taking the spotlight to share her experience with GLP-1s. Don Arnold/Getty Images Oprah

Novo’s Wegovy Pill Looks A Lot Like Zepbound — In One Week  Investor’s Business Daily Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’

Novo’s Wegovy pill tracks 3,071 prescriptions in first days of launch  Reuters Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch  CNBC Lubbock Doctor

America’s restaurant industry is quietly reworking its playbook as weight-loss drugs change how people eat, how much food they leave behind and what they are

Join the American Heart Association for an insightful session with Dr. Clyde Yancy and Dr. Dhruv Kazi. Recent clinical trials demonstrate the efficacy of incretin-based

In my column last Monday, I wrote about how to make better New Year’s resolutions—ones that are less likely to flop, but that are also

More than 3,000 prescriptions were written for Novo’s GLP-1 pill in its first week on the market. Elsewhere, Emergent reached a settlement over a trading

President Donald Trump touted Friday his new health care plan, which he dubbed “The Great Health Care Plan” during a press conference from the White

Oprah dropped about 50 pounds after going on GLP-1 drugs two and a half years ago, but then quickly gained back 20 pounds when she

The glucagon-like peptide-1 receptor (GLP-1R) is a class B1 G protein–coupled receptor and major therapeutic target in type 2 diabetes and obesity. Beyond its canonical

Historically, antiobesity medications have been modestly effective at best, with side-effect profiles that limit compliance and often preclude the long-term therapy required to maintain weight

Welcome to this week’s Food Exec Brief, your strategic intelligence roundup covering the industry’s desperate fight to preserve margins amid relentless cost pressures, AI and

Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from

A major fast-food chain is revamping its value menu as diners grow more price-conscious — and the early reaction is split. Taco Bell is expanding

Most current GLP-1 users are interested in switching to an oral form KIRKLAND, Wash., Jan. 16, 2026 /PRNewswire/ — A new survey from Sunlight.com finds

SAN FRANCISCO — Throughout his 53 meetings at this year’s JPMorgan Healthcare Conference, Richard Saynor mulled a charitable idea about the topic on everyone’s minds.

Resmed highlights AI-driven CPAP tech, competitive bidding win and GLP-1 insights at J.P. Morgan Hea  HME News

Signal Boost 2026 Second week of January. Year of the Horse. Back in the saddle. As I point my GPS toward a familiar constellation of

Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns

Fermentation, Vol. 12, Pages 53: High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli Fermentation doi: 10.3390/fermentation12010053 Authors:

Get the Highest Quality Electrolyte https://euvexia.com . Losing belly fat is hard so you may wonder if a GLP-1 will work. The question isn’t whether

Peter Rahal, David Protein CEO, joins ‘Squawk Box’ to discuss the rise and advancements of protein bars, the supplementation of creatine, impact of GLP-1 weight

Nature Cancer, Published online: 16 January 2026; doi:10.1038/s43018-025-01110-1 Yabut and Drucker discuss clinical and preclinical evidence about the potential roles of GLP-1 medicines on cancer

Chad Finkelstein is a partner at the law firm of Dale & Lessmann LLP and chair of the firm’s franchising, licensing and distribution group. His

At biopharma’s biggest conference, leaders plot strategy

Oprah Winfrey is no stranger to the limelight or public scrutiny. But her negative experience with the late Joan Rivers is still something that sticks

Like clockwork, the turn of the new calendar year always brings a slew of chatter about weight loss, diets and exercise. Whether it’s in the form

Hair loss often shows up when something deeper in your metabolism starts to break down, and glucagon-like peptide-1 (GLP-1) drugs push that process forward in

Source: https://finance.yahoo.com/news/strive-compounding-pharmacy-files-landmark-200600637.html Strive Compounding Pharmacy, one of the nation’s most celebrated providers of compounded medications, has filed a federal antitrust lawsuit against pharmaceutical giants Eli

Post Content

President Donald Trump released a sparsely detailed healthcare policy framework Jan. 15 that calls on Congress to codify voluntary drug pricing agreements with major pharmaceutical

Now the 51-year-old reality star has shared if she plans to go off the weight loss drug. The answer is a big no, even though

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s  Sherwood News Strive Compounding Pharmacy Files Landmark Antitrust Lawsuit Against Eli Lilly and Novo Nordisk  Yahoo

Ashton Kutcher has no love lost for his ex-wife, Demi Moore. “Demi’s performance in The Substance, obviously, got extraordinary accolades. I’m so proud of her,”